Josef D Järhult Selected Research

oseltamivir carboxylate

5/2016	Fate of three anti-influenza drugs during ozonation of wastewater effluents - degradation and formation of transformation products.
4/2015	Oseltamivir-resistant influenza A (H1N1) virus strain with an H274Y mutation in neuraminidase persists without drug pressure in infected mallards.
1/2012	Oseltamivir (Tamiflu(®)) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans - a review.
1/2011	Environmental levels of the antiviral oseltamivir induce development of resistance mutation H274Y in influenza A/H1N1 virus in mallards.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Josef D Järhult Research Topics

Disease

12	Human Influenza (Influenza) 01/2020 - 06/2009
6	Infections 01/2021 - 01/2011
5	Influenza in Birds (Avian Flu) 09/2020 - 01/2012
2	COVID-19 01/2021 - 10/2020
1	Dengue (Dengue Fever) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Viremia 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Hypoxia (Hypoxemia) 10/2020
1	Severe Acute Respiratory Syndrome 10/2020
1	Neoplasms (Cancer) 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Persistent Infection 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Acute-Phase Reaction 01/2020
1	Bacterial Infections (Bacterial Infection) 01/2018

Drug/Important Bio-Agent (IBA)

10	Oseltamivir (Tamiflu)FDA Link 01/2020 - 06/2009
7	Neuraminidase (Sialidase)IBA 01/2018 - 01/2011
6	Antiviral Agents (Antivirals)IBA 10/2020 - 06/2009
6	Pharmaceutical PreparationsIBA 01/2018 - 01/2011
4	oseltamivir carboxylateIBA 05/2016 - 01/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
2	Viral RNAIBA 09/2020 - 01/2013
2	Zanamivir (Relenza)FDA Link 01/2020 - 05/2016
2	VaccinesIBA 01/2018 - 12/2017
1	Colistin (Coly-Mycin)FDA Link 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Vasodilator Agents (Vasodilators)IBA 10/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2020
1	Hemagglutinins (Hemagglutinin)IBA 06/2020
1	Single-Stranded DNA (DNA, Single Stranded)IBA 01/2020
1	AntibodiesIBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	HaptoglobinsIBA 01/2020
1	Immunoglobulin M (IgM)IBA 01/2020
1	CoagulaseIBA 01/2019
1	Linezolid (Zyvox)FDA Link 01/2019
1	asoxime chloride (H16)IBA 01/2019
1	WastewaterIBA 05/2016
1	Amantadine (Aman)FDA LinkGeneric 05/2016
1	OzoneIBA 05/2016
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2013
1	Viral AntigensIBA 01/2013

Therapy/Procedure

1	Off-Label Use 01/2019